|
Press Releases |
|
![](/images/company/BaseCare.jpg) |
|
Monday, July 15, 2024 |
|
醫療器械是否回暖 貝康醫療(2170.HK)上半年銷售業績逆勢爆發 |
貝康醫療(2170.HK)於7月12日發佈了未經審計的半年度業績預告,公告顯示公司上半年收入約為1.27億至1.38億人民幣,較去年同期增長約49%至62%。 more info >> |
|
医疗器械是否回暖 贝康医疗(2170.HK)上半年销售业绩逆势爆发 |
贝康医疗(2170.HK)于7月12日发布了未经审计的半年度业绩预告,公告显示公司上半年收入约为1.27亿至1.38亿人民币,较去年同期增长约49%至62%。 more info >> |
|
Monday, August 29, 2022 |
|
贝康医疗公布2022年中期业绩 做强技术创新 |
中国辅助生殖基因检测解决方案的创新平台苏州贝康医疗股份有限公司(“贝康医疗”或“公司”,及其子公司,统称“集团”;股份代号:2170) 公布截至 2022 年 6 月 30 日止六个月(“期内”)之未经审核综合业绩。 more info >> |
|
貝康醫療公佈2022年中期業績 做強技術創新 |
中國輔助生殖基因檢測解決方案的創新平台蘇州貝康醫療股份有限公司(「貝康醫療」或「公司」,及其子公司,統稱「集團」;股份代號:2170) 公佈截至 2022 年 6 月 30 日止六個月(「期內」)之未經審核綜合業績。 more info >> |
|
Strengthen technological innovation, Basecare Medical Announces 2022 Interim Results |
Suzhou Basecare Medical Corporation Limited ("Basecare Medical" or the "Company", together with its subsidiaries, the "Group", stock code: 2170), an innovative platform of genetic testing solutions for assisted reproduction in China, officially announced the unaudited consolidated interim results for the six months ended June 30, 2022 (the "Reporting Period"). more info >> |
|
Thursday, July 14, 2022 |
|
贝康医疗与海尔生物强强联合,构建辅助生殖低温保存解决方案 |
苏州贝康医疗股份有限公司(以下简称“贝康医疗”)与青岛海尔生物医疗股份有限公司(以下简称“海尔生物”)正式签署战略合作协议。 more info >> |
|
貝康醫療與海爾生物強強聯合,構建輔助生殖低溫保存解決方案 |
蘇州貝康醫療股份有限公司(以下簡稱「貝康醫療」)與青島海爾生物醫療股份有限公司(以下簡稱「海爾生物」)正式簽署戰略合作協議。 more info >> |
|
Basecare Medical and Haier Biomedical Join Forces to Build Cryopreservation Solutions for Assisted Reproduction |
Suzhou Basecare Medical Corporation Limited ("Basecare Medical" or the "Company", together with its subsidiaries, the "Group", stock code: 2170) officially announced that the Company entered into a strategic collaboration framework agreement with Qingdao Haier Biomedical Co., Ltd. more info >> |
|
Thursday, March 31, 2022 |
|
贝康医疗公布2021年全年业绩,收入毛利录得双增长 |
中国辅助生殖基因检测解决方案的创新平台苏州贝康医疗股份有限公司(“贝康医疗”或“公司”,及其子公司,统称“集团”;股份代号:2170) 公布截至2021年12月31日止年度(“年内”)之经审核综合业绩。 more info >> |
|
貝康醫療公佈2021年全年業績,收入毛利錄得雙增長 |
中國輔助生殖基因檢測解決方案的創新平台蘇州貝康醫療股份有限公司(「貝康醫療」或「公司」,及其子公司,統稱「集團」;股份代號:2170) 公佈截至2021年12月31日止年度(「年內」)之經審核綜合業績。 more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
エーザイ、ホスラブコナゾールのアジア・オセアニアにおけるライセンス契約を佐藤製薬と締結
Jul 16, 2024 13:00: JST
|
|
|
富士通とCohere、企業向け生成AIの提供に向けた戦略的パートナーシップを締結し、共同開発を開始
Jul 16, 2024 13:00: JST
|
|
|
卓悅集團旗下卓悅奧特萊斯Beauty Outlet開幕
Jul 15, 2024 22:58 HKT/SGT
|
|
|
Malaysian Aviation Commission Handpicks Indonesia's TransNusa Airlines as One of the Two Foreign Airlines to Operate from its distinguished Subang Airport
Jul 15, 2024 22:00: JST
|
|
|
Malaysian Aviation Commission Handpicks Indonesia's TransNusa Airlines as One of the Two Foreign Airlines to Operate from its distinguished Subang Airport
Jul 15, 2024 21:00 HKT/SGT
|
|
|
卓悦集团旗下卓悦奥特莱斯Beauty Outlet开幕
Jul 15, 2024 20:56 HKT/SGT
|
|
|
Moolec Signs an Offtake Agreement With Major Global CPG Company to Hit the US Market in 2025
Jul 15, 2024 19:00 HKT/SGT
|
|
|
Telin and BW Digital to enhance DC-to-DC connectivity with new Indonesia - Singapore cable
Jul 15, 2024 17:50 HKT/SGT
|
|
|
Legend Capital's Portfolio Company Singfilm Solar Achieves Breakthrough in Perovskite Solar Cell Efficiency
Jul 15, 2024 17:10 HKT/SGT
|
|
|
NEC transfers a portion of its shares in NEC Capital Solutions, an equity method affiliate
Jul 15, 2024 16:58 JST
|
|
|
DENSO Hosts Software Strategy Briefing, Shares Company Direction
Jul 15, 2024 15:05 JST
|
|
|
Komisi Penerbangan Malaysia Memilih TransNusa Sebagai Salah Satu Dari Dua Maskapai Asing Untuk Meluncurkan Penerbangan Dari Bandara Subang
Jul 15, 2024 14:00 HKT/SGT
|
|
|
The Malaysian Aviation Commission Handpicks TransNusa as One of Two Foreign Airlines to Launch Flights from Subang Airport
Jul 15, 2024 14:00 HKT/SGT
|
|
|
醫療器械是否回暖 貝康醫療(2170.HK)上半年銷售業績逆勢爆發
Jul 15, 2024 08:51 HKT/SGT
|
|
|
foundit Survey: 52% of Singaporean organisations show responsiveness to diversity issues, highlighting key growth opportunities
Jul 15, 2024 08:00 HKT/SGT
|
|
|
|
More News >> |
|
|
|
|
|